Modena’s New Crown vaccine became the second new crown vaccine approved by the U.S. Food and Drug Administration (FDA) for emergency use on Friday (Dec. 18).
Modena will provide millions of vaccines for a rollout that begins this week for health care workers first. Older adults in nursing homes will be the next to receive the vaccine.
A Centers for Disease Control and Prevention panel will make recommendations for various populations this Sunday.
The FDA announced the approval of emergency use of the Modena vaccine the day after the FDA’s external panel supported its use and a week after the FDA approved the vaccine from Pfizer and its partner BioNTech SE.
Modena’s goal is for its vaccine to be used in hard-to-deliver places, such as rural hospitals. The vaccine requires cryopreservation and transport, but not the supercooled temperatures required for Pfizer’s vaccine.
Despite some public hesitation, the speed of the vaccine’s development — less than a year after the first patient with the new coronavirus was discovered in the U.S. — has yielded amazing scientific results.
Moderna plans to apply for a full U.S. license in 2021. the FDA’s decision marks the first worldwide surveillance authorization for the Moderna vaccine and its messenger RNA technology, showing nearly 95% efficacy and no serious safety concerns.
The United States can expect to provide 40 million doses of the vaccine by the end of this year after approving the use of two new crown vaccines that can be used to vaccinate 20 million people. Both vaccines require two injections.
Recent Comments